How many drugs treat Perennial allergic rhinitis?

Drug Landscape tracks 2 marketed treatments for Perennial allergic rhinitis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/perennial-allergic-rhinitis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Perennial allergic rhinitis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Perennial allergic rhinitis (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Perennial allergic rhinitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Mizollen	MIZOLASTINE	Sanofi	mizolastine	Histamine H1 receptor		1998-01-01
Depo-Medrol	METHYLPREDNISOLONE ACETATE	Pfizer	Corticosteroid	Glucocorticoid receptor		1959-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 1 drug in Perennial allergic rhinitis
Sanofi · 1 drug in Perennial allergic rhinitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Perennial allergic rhinitis:

Cite this brief

Drug Landscape (2026). Perennial allergic rhinitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/perennial-allergic-rhinitis. Accessed 2026-06-10.

Perennial allergic rhinitis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing